Medium materiality5/10
Replimune price target raised to $9 from $6 at Wedbush
Why it may matterVerify against the original reporting
bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wedbush raises REPL target to $9; price $11.2.
- Target $9; price $11.2
Key facts
- 01
Target: $9
- 02
Posted price: $11.2
- 03
Analyst firm: Wedbush
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.